Vietnam Medical and Pharmaceutical Investment JSC

Vietnam Medical and Pharmaceutical Investment JSC maintains a debt-to-equity ratio of 0.51 and a current ratio of 1.78, indicating a moderate level of liquidity and a balanced capital structure. The company's liquidity is assessed as medium, with a negative net cash position after subtracting total debt. The company's profitability is reflected in a return on equity of 8.47% and a return on assets of 4.66%, which are key metrics for evaluating performance in the Advanced Medical Equipment & Technology industry. These figures suggest that the company is generating returns that are in line with industry expectations. The company's revenue is primarily derived from the distribution of medical equipment and related services. While the input data does not provide specific segment or geographic revenue breakdowns, the company's operations are concentrated in Vietnam, indicating a potential risk of revenue concentration. The company's growth trajectory is not explicitly detailed in the input data, but the financial snapshot indicates a net income of 49,945,279,760 VND, suggesting a profitable operation. The outlook for the current and next fiscal years is not provided, but the company's performance in the most recent period indicates a positive trend. The risk assessment indicates a low potential for dilution, with no immediate pressure for share issuance. The company's liquidity risk is moderate, and the credit risk is not explicitly detailed in the input data. The company's capital structure and financial performance suggest a stable position, but the negative net cash position after subtracting total debt is a key flag to monitor. Recent events, such as filings and transcripts, are not detailed in the input data. However, the company's financial performance and risk assessment suggest a stable and profitable operation with a moderate level of liquidity.